Bryostatin and CD40-ligand enhance apoptosis resistance and induce expression of cell survival genes in B-cell chronic lymphocytic leukaemia.
about
The outcome of B-cell receptor signaling in chronic lymphocytic leukemia: proliferation or anergyProtein kinase C regulates FADD recruitment and death-inducing signaling complex formation in Fas/CD95-induced apoptosisEmerging drugs for chronic lymphocytic leukaemia.Early induction of apoptosis in B-chronic lymphocytic leukaemia cells by hydroxychloroquine: activation of caspase-3 and no protection by survival factors.Different proliferative and survival capacity of CLL-cells in a newly established in vitro model for pseudofollicles.Comparative analysis of MVA-CD40L and MVA-TRICOM vectors for enhancing the immunogenicity of chronic lymphocytic leukemia (CLL) cells.Latent sensitivity to Fas-mediated apoptosis after CD40 ligation may explain activity of CD154 gene therapy in chronic lymphocytic leukemiaExploiting biological diversity and genomic aberrations in chronic lymphocytic leukemia.The apoptotic pathway: a target for therapy in chronic lymphocytic leukemia.Lycorine sensitizes CD40 ligand-protected chronic lymphocytic leukemia cells to bezafibrate- and medroxyprogesterone acetate-induced apoptosis but dasatanib does not overcome reported CD40-mediated drug resistance.CD40 ligand (CD154) and tumour necrosis factor-related apoptosis inducing ligand (Apo-2L) in haematological malignancies.Apoptosis in lymphocytic leukemias and lymphomas.Mechanism of action of purine analogues in chronic lymphocytic leukaemia.Tracking death dealing by Fas and TRAIL in lymphatic neoplastic disorders: pathways, targets, and therapeutic tools.Bryostatin-1: a novel PKC inhibitor in clinical development.Protein kinases in the regulation of apoptosis in B-cell chronic lymphocytic leukemia.Co-culture of primary CLL cells with bone marrow mesenchymal cells, CD40 ligand and CpG ODN promotes proliferation of chemoresistant CLL cells phenotypically comparable to those proliferating in vivoThe cytotoxicity of anti-CD22 immunotoxin is enhanced by bryostatin 1 in B-cell lymphomas through CD22 upregulation and PKC-βII depletion.Mammalian target of rapamycin (mTOR) inhibition in chronic lymphocytic B-cell leukemia: a new therapeutic option.Expression and function of the TL1A/DR3 axis in chronic lymphocytic leukemia.The antileukemia activity of a human anti-CD40 antagonist antibody, HCD122, on human chronic lymphocytic leukemia cellsBiology of chronic lymphocytic leukemia in different microenvironments: clinical and therapeutic implications.Vinblastine rapidly induces NOXA and acutely sensitizes primary chronic lymphocytic leukemia cells to ABT-737.Phase I study of the anti-CD40 humanized monoclonal antibody lucatumumab (HCD122) in relapsed chronic lymphocytic leukemiaAdoptive T-cell immunotherapy of chronic lymphocytic leukaemia.Blinatumomab induces autologous T-cell killing of chronic lymphocytic leukemia cells.Curcumin inhibits prosurvival pathways in chronic lymphocytic leukemia B cells and may overcome their stromal protection in combination with EGCG.The microenvironment in mature B-cell malignancies: a target for new treatment strategiesTreatment of chronic lymphocytic leukemia requires targeting of the protective lymph node environment with novel therapeutic approaches.Structure and function of the hematopoietic cancer niche: focus on chronic lymphocytic leukemia."Role of the B-cell receptor and the microenvironment in chronic lymphocytic leukemia''.Microenvironment interactions and B-cell receptor signaling in Chronic Lymphocytic Leukemia: Implications for disease pathogenesis and treatment.The Central Role for Microenvironment in B-Cell Malignancies: Recent Insights into Synergistic Effects of its Therapeutic Targeting and Anti-CD20 Antibodies.Modeling the chronic lymphocytic leukemia microenvironment in vitro.CD40·FasL and CTLA-4·FasL fusion proteins induce apoptosis in malignant cell lines by dual signaling.Macrophages confer survival signals via CCR1-dependent translational MCL-1 induction in chronic lymphocytic leukemia.Engagement of the B-cell antigen receptor (BCR) allows efficient transduction of ZAP-70-positive primary B-CLL cells by recombinant adeno-associated virus (rAAV) vectors.Treatment-induced expression of anti-apoptotic proteins in WSU-CLL, a human chronic lymphocytic leukemia cell line.CD154 induces p73 to overcome the resistance to apoptosis of chronic lymphocytic leukemia cells lacking functional p53.Inhibitors of XIAP sensitize CD40-activated chronic lymphocytic leukemia cells to CD95-mediated apoptosis.
P2860
Q26865760-7E6FDA83-83FD-4BE5-A1B8-F0590EC01E5DQ28189776-B1C51E45-5588-4519-95BA-991B20B3B6D2Q30353154-387873C0-1D86-4802-A5DD-57260503EF95Q31893630-2F66B851-7302-4933-836F-17E7CBE5A0C6Q33385676-621A1218-BDAD-4CEC-A81F-61225327233CQ33938820-A94B756B-2500-4EE1-88DB-4283F0958410Q34020828-41C761CC-CB22-4B22-B5B8-CFBCEE8FC5E6Q34056568-58015DE6-3F1A-4F97-A6A7-20E70A067169Q34057963-90B5CD54-4E60-418C-8697-1148726E69F1Q34255124-E98A16AC-3A8F-469E-B8E2-8EC5EE6907C8Q34266298-3A62F87F-2AA2-4963-B64C-BF1BEF9065C3Q34798677-AA02D86A-9730-43DF-B0F1-7FA1B8AA3401Q35142707-C6C58939-C067-4C48-9216-8C4189DC1447Q35209364-1BA6E7FB-EAE7-4136-8733-BE009AAE48DDQ35634829-E08563E7-D14E-401E-B833-CF6D4142C055Q35635542-FBC2D5F6-D933-4E47-A54B-02B13F657D40Q35781372-0097E803-264F-4EF6-80B7-87717F39F8BAQ35930653-B0DC7949-C332-406F-B712-874A0B3BAA61Q35994885-A7F56B82-487C-4BF7-A9D7-344D108AB11DQ36544769-C69856F2-4629-4CA1-9554-B17D3F0D3EA3Q36787532-2A56AA9E-C84D-40DD-9B67-F53C11D43430Q36862781-6C726A21-B581-4B78-953E-D7CF7FF2631AQ37092954-1F491E9D-5689-4D19-8665-A471A53CEFB6Q37257024-4B43DBED-8BA4-44F1-8148-EC35EB8ED570Q37268297-328386FE-BAAF-4ECF-B873-6F69F8A69B48Q37378009-1E04A5E4-74AC-49FD-8114-33A55CF9EDF8Q37483502-57BBF22F-0535-466F-8248-61FD1252BDCAQ37563816-F567C4A7-9C49-4277-B30F-B88B2F5D7D29Q37910914-A6881914-203C-447F-942C-E5E74DA504DFQ37971736-5A606A30-D3D7-4A09-BE38-F108725D3E25Q38140625-EFE535EF-1054-491F-89BE-48B793B628C7Q38550810-4124A6C0-1DC7-4C06-AD16-56D86C4B517FQ38577849-3BE8BDCE-EBE6-4D97-BC21-6785F10CDD87Q38984569-3E42EB91-C8B9-4404-BCDF-7D89421B3A20Q39630040-8C2AD2B0-378C-439E-AB1B-2E805E0C2ECDQ40338396-D22FBBD3-C3C1-4708-B90F-8630EDB2C7AEQ40532563-00268C4D-C087-4703-9749-8976E914076EQ40760110-5AE84569-79D2-4F01-AEF0-EABC5169A1E8Q41953887-953A8261-81F3-4302-8493-781407129E88Q42089513-716E4D9A-0289-4458-A140-A52CFCC4DA76
P2860
Bryostatin and CD40-ligand enhance apoptosis resistance and induce expression of cell survival genes in B-cell chronic lymphocytic leukaemia.
description
1999 nî lūn-bûn
@nan
1999年の論文
@ja
1999年論文
@yue
1999年論文
@zh-hant
1999年論文
@zh-hk
1999年論文
@zh-mo
1999年論文
@zh-tw
1999年论文
@wuu
1999年论文
@zh
1999年论文
@zh-cn
name
Bryostatin and CD40-ligand enh ...... chronic lymphocytic leukaemia.
@en
type
label
Bryostatin and CD40-ligand enh ...... chronic lymphocytic leukaemia.
@en
prefLabel
Bryostatin and CD40-ligand enh ...... chronic lymphocytic leukaemia.
@en
P2093
P2860
P1476
Bryostatin and CD40-ligand enh ...... chronic lymphocytic leukaemia
@en
P2093
P2860
P304
P356
10.1046/J.1365-2141.1999.01642.X
P407
P577
1999-09-01T00:00:00Z